30 research outputs found

    Induced astigmatism and concomitant high myopia correction with femtosecond laser-assisted intrastromal MyoRing implantation

    Get PDF
    Purpose. Analysis of the results of astigmatism correction after penetrating keratoplasty and concomitant high myopia using the MyoRing ring implantation, clinical case as an example.Material and methods. Patient G., 51 years old, underwent surgery to correct astigmatism and concomitant high myopia. MyoRing was implanted in the right eye within corneal transplant limits using femtosecond laser-assisted intrastromal MyoRing implantation. Before the surgery uncorrected visual acuity at the operated eye was 0.01; corrected visual acuity 0.06; spherical component of refraction was (-)6.0 D, cylindrical component was (-)8.0 D. Mean keratometry in the right eye was 43.96 D. Corneal hysteresis was 6.5 mm Hg, corneal resistance factor was 5.5 mm Hg, cornea thickness in center was 529 mkm. The patient was followed up for one year.Results. In 12 months after the surgery visual acuity of the right eye without correction was 0.7 and 0.8 with correction. Spherical component was (-)1.0 D, cylindrical component was (-)2.0 D. Mean keratometry in the right eye was 35.10 D. Corneal hysteresis was 7.2 mm Hg, corneal resistance factor was 6.3 mm Hg, cornea thickness in center was 533 mkm. The patient was satisfied with the result of operation.Conclusion. Femtosecond laser-assisted intrastromal MyoRing implantation for correction induced astigmatism after penetrating keratoplasty and concomitant high myopia is efficient, safe and provides strengthening of biomechanical properties of the cornea besides refractive and visual effect

    Control of Organic Impurities in Semisynthetic Antibiotics

    Get PDF
    In 2012, the European Medicines Agency (EMA) adopted a guideline, which divided all antibiotics into groups according to the manufacturing process and established acceptance criteria for organic impurities for each of the groups.The aim of the study was to justify the requirements and methodological approaches to setting the limits for organic impurities in semisynthetic antibiotics.Materials and methods: the authors analysed the requirements established by the leading world pharmacopoeias and the State Pharmacopoeia of the Russian Federation regarding the control of organic impurities in semisynthetic antibiotics, using the example of four semisynthetic antibiotics: doxycyline hyclate, clarithromycin, meropenem, and ceftriaxone. The study used the methods of comparative analysis and content analysis. Results: the study demonstrated that the organic impurity profiles of the analysed active substances and the corresponding finished medicinal products often differ significantly across the leading pharmacopoeias, either qualitatively or quantitatively. The Russian, European, and United States pharmacopoeias provide for the use of impurity reference standards in the test procedures for the determination of impurities in active substances of the semisynthetic antibiotics in question, whereas the Japanese Pharmacopoeia allows the use of non-compendial reference substances in the assessment of the chromatographic system separation power.Conclusions: the ability of a pharmacopoeial text to cover a variety of medicinal products coming to the Russian market from different countries has become a vital issue. This includes covering the impurity determination procedures, reference standards, and limits used, because general-purpose methods and limits do not always allow for correct assessment of impurity profiles in substances produced by different manufacturing processes. The current USP practice is to include various impurity control procedures in monographs on medicinal products, and the limits may also vary. This approach may be applied in the State Pharmacopoeia of the Russian Federation as well

    Correction of postkeratoplastic astigmatism by intrastromal corneal segments implantation using a femtosecond laser

    Get PDF
    Background. After penetrating keratoplasty, mild to high induced corneal astigmatism was observed in each case. The existing choice of correction of postkeratoplastic astigmatism is aimed at fi nding an individual approach in order to compensate for it and not weaken the biomechanical properties of the corneal graft.The aim: to analyze the clinical, functional, and morphological results of postkeratoplastic astigmatism correction by implantation of intrastromal corneal segments using a femtosecond laser.Methods. 22 patients were examined before and 1 year after surgery. The operation was performed under local anesthesia: stage I – an intrastromal tunnel was formed using a femtosecond laser β€œFemto Visum” 1 MHz (Optosystems, Russia); stage II – the intrastromal corneal segments were implanted. The results were assessed using standard and special research methods using optical coherence tomography Visante OCT (Zeiss, Germany), keratotopography (Tomey-5, Japan), optical corneal analyzer ORA (Reichert, USA), laser tindalemetry FC-2000 (Kowa, Japan) and confocal microscope Confoscan-4 (Nidek, Japan).Results. Before the operation, uncorrected visual acuity averaged 0.09 Β± 0.05, after a year – 0.50 Β± 0.16; best corrected visual acuity – 0.30 Β± 0.12 and 0.60 Β± 0.05 respectively; cylindrical component of refraction – –10.29 Β± 3.12 and –2.20 Β± 0.64 D respectively; mean keratometry value – 43.59 Β± 2.14 and 38.56 Β± 1.75 D respectively; corneal hysteresis – 7.92 Β± 1.22 and 8.95 Β± 1.05 mm Hg respectively; corneal resistance factor – 7.01 Β± 1.81 and 8.44 Β± 1.44 mm Hg respectively; protein fl ux in the moisture of the anterior chamber – 2.97 Β± 0.28 and 3.04 Β± 0.24 f/ms respectively; endothelial cell density – 1521 Β± 327 and 1475 Β± 419 cells/mm2 respectively.Conclusion. Intrastromal corneal segments implantation into a corneal graft using a femtosecond laser has efficiency and safety method in correcting postkeratoplastic astigmatism

    A process-based model of methane consumption by upland soils

    Get PDF
    This study combines a literature survey and field observation data in an ad initio attempt to construct a process-based model of methane sink in upland soils including both the biological and physical aspects of the process. Comparison is drawn between the predicted sink rates and chamber measurements in several forest and grassland sites in the southern part of West Siberia. CH4 flux, total respiration, air and soil temperature, soil moisture, pH, organic content, bulk density and solid phase density were measured during a field campaign in summer 2014. Two datasets from literature were also used for model validation. The modeled sink rates were found to be in relatively good correspondence with the values obtained in the field. Introduction of the rhizospheric methanotrophy significantly improves the match between the model and the observations. The Q10 values of methane sink observed in the field were 1.2-1.4, which is in good agreement with the experimental results from the other studies. Based on modeling results, we also conclude that soil oxygen concentration is not a limiting factor for methane sink in upland forest and grassland ecosystems.Peer reviewe

    ΠšΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŒ органичСских примСсСй Π² полусинтСтичСских Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊΠ°Ρ…

    Get PDF
    In 2012, the European Medicines Agency (EMA) adopted a guideline, which divided all antibiotics into groups according to the manufacturing process and established acceptance criteria for organic impurities for each of the groups.The aim of the study was to justify the requirements and methodological approaches to setting the limits for organic impurities in semisynthetic antibiotics.Materials and methods: the authors analysed the requirements established by the leading world pharmacopoeias and the State Pharmacopoeia of the Russian Federation regarding the control of organic impurities in semisynthetic antibiotics, using the example of four semisynthetic antibiotics: doxycyline hyclate, clarithromycin, meropenem, and ceftriaxone. The study used the methods of comparative analysis and content analysis. Results: the study demonstrated that the organic impurity profiles of the analysed active substances and the corresponding finished medicinal products often differ significantly across the leading pharmacopoeias, either qualitatively or quantitatively. The Russian, European, and United States pharmacopoeias provide for the use of impurity reference standards in the test procedures for the determination of impurities in active substances of the semisynthetic antibiotics in question, whereas the Japanese Pharmacopoeia allows the use of non-compendial reference substances in the assessment of the chromatographic system separation power.Conclusions: the ability of a pharmacopoeial text to cover a variety of medicinal products coming to the Russian market from different countries has become a vital issue. This includes covering the impurity determination procedures, reference standards, and limits used, because general-purpose methods and limits do not always allow for correct assessment of impurity profiles in substances produced by different manufacturing processes. The current USP practice is to include various impurity control procedures in monographs on medicinal products, and the limits may also vary. This approach may be applied in the State Pharmacopoeia of the Russian Federation as well.Π’ 2012 Π³. ЕвропСйским агСнтством ΠΏΠΎ лСкарствСнным срСдствам (European Medicines Agency, Π•ΠœΠ) ΡƒΡ‚Π²Π΅Ρ€ΠΆΠ΄Π΅Π½ΠΎ руководство, согласно ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠΌΡƒ всС Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊΠΈ Ρ€Π°Π·Π΄Π΅Π»Π΅Π½Ρ‹ Π½Π° Π³Ρ€ΡƒΠΏΠΏΡ‹ Π² соотвСтствии с Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠ΅ΠΉ ΠΈΡ… получСния. Для ΠΊΠ°ΠΆΠ΄ΠΎΠΉ Π³Ρ€ΡƒΠΏΠΏΡ‹ установлСны ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠΈ приСмлСмости содСрТания органичСских примСсСй.ЦСль Ρ€Π°Π±ΠΎΡ‚Ρ‹: ΠΎΠ±ΠΎΡΠ½ΠΎΠ²Π°Ρ‚ΡŒ трСбования ΠΈ мСтодичСскиС ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Ρ‹ ΠΊ ΠΊΠΎΠ½Ρ‚Ρ€ΠΎΠ»ΡŽ органичСских примСсСй Π² лСкарствСнных срСдствах полусинтСтичСских Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊΠΎΠ².ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹: ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Ρ‚Ρ€Π΅Π±ΠΎΠ²Π°Π½ΠΈΠΉ отСчСствСнной ΠΈ Π²Π΅Π΄ΡƒΡ‰ΠΈΡ… Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹Ρ… Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΠ΅ΠΉ ΠΊ допустимому ΡΠΎΠ΄Π΅Ρ€ΠΆΠ°Π½ΠΈΡŽ органичСских примСсСй Π² полусинтСтичСских Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊΠ°Ρ… Π½Π° ΠΏΡ€ΠΈΠΌΠ΅Ρ€Π΅ Ρ‡Π΅Ρ‚Ρ‹Ρ€Π΅Ρ… ΠΈΠ· Π½ΠΈΡ…: доксициклина Ρ…ΠΈΠΊΠ»Π°Ρ‚, ΠΊΠ»Π°Ρ€ΠΈΡ‚Ρ€ΠΎΠΌΠΈΡ†ΠΈΠ½, ΠΌΠ΅Ρ€ΠΎΠΏΠ΅Π½Π΅ΠΌ ΠΈ цСфтриаксон. Π’ Ρ€Π°Π±ΠΎΡ‚Π΅ использовали ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹ ΡΡ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΎΠ½Π½ΠΎ-аналитичСского исслСдования ΠΈ ΠΊΠΎΠ½Ρ‚Π΅Π½Ρ‚-Π°Π½Π°Π»ΠΈΠ·Π°.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹: ΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ, Ρ‡Ρ‚ΠΎ ΠΏΡ€ΠΎΡ„ΠΈΠ»ΡŒ органичСских примСсСй Π² монографиях Π²Π΅Π΄ΡƒΡ‰ΠΈΡ… Π·Π°Ρ€ΡƒΠ±Π΅ΠΆΠ½Ρ‹Ρ… Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΠ΅ΠΉ Π½Π° ΠΎΠ΄Π½ΠΎΠΈΠΌΠ΅Π½Π½ΡƒΡŽ Ρ„Π°Ρ€ΠΌΠ°Ρ†Π΅Π²Ρ‚ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ ΡΡƒΠ±ΡΡ‚Π°Π½Ρ†ΠΈΡŽ, Π° Ρ‚Π°ΠΊΠΆΠ΅ лСкарствСнный ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚, для ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΠΈΠ· исслСдуСмых лСкарствСнных срСдств, ΠΊΠ°ΠΊ ΠΏΡ€Π°Π²ΠΈΠ»ΠΎ, различаСтся Π»ΠΈΠ±ΠΎ качСствСнно, Π»ΠΈΠ±ΠΎ количСствСнно. Π’ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠ°Ρ… опрСдСлСния примСсСй для фармацСвтичСских субстанций рассматриваСмых полусинтСтичСских Π°Π½Ρ‚ΠΈΠ±ΠΈΠΎΡ‚ΠΈΠΊΠΎΠ² согласно ГосударствСнной Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΠ΅Π΅ Российской Π€Π΅Π΄Π΅Ρ€Π°Ρ†ΠΈΠΈ (Π“Π€ Π Π€), ЕвропСйской Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΠ΅Π΅ ΠΈ Π€Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΠ΅Π΅ БША прСдусмотрСно ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ стандартных ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ² примСсСй, Ρ‚ΠΎΠ³Π΄Π° ΠΊΠ°ΠΊ Японская фармакопСя для ΠΎΡ†Π΅Π½ΠΊΠΈ Ρ€Π°Π·Π΄Π΅Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ способности хроматографичСской систСмы допускаСт использованиС вСщСств, ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Π΅ Π½Π΅ ΡΠ²Π»ΡΡŽΡ‚ΡΡ Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΠ΅ΠΉΠ½Ρ‹ΠΌΠΈ стандартными ΠΎΠ±Ρ€Π°Π·Ρ†Π°ΠΌΠΈ.Π’Ρ‹Π²ΠΎΠ΄Ρ‹: Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Ρ‹ΠΌ вопросом становится ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡ‚ΡŒ Ρ„Π°Ρ€ΠΌΠ°ΠΊΠΎΠΏΠ΅ΠΉΠ½ΠΎΠ³ΠΎ стандарта ΡƒΡ‡ΠΈΡ‚Ρ‹Π²Π°Ρ‚ΡŒ ΠΌΠ½ΠΎΠ³ΠΎΠΎΠ±Ρ€Π°Π·ΠΈΠ΅ лСкарствСнных срСдств, ΠΏΠΎΡΡ‚ΡƒΠΏΠ°ΡŽΡ‰ΠΈΡ… Π½Π° российский Ρ€Ρ‹Π½ΠΎΠΊ ΠΈΠ· Ρ€Π°Π·Π½Ρ‹Ρ… стран. Π­Ρ‚ΠΎ касаСтся ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΡ‹Ρ… ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊ опрСдСлСния примСсСй, примСнСния стандартных ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ², Π½ΠΎΡ€ΠΌ, ΠΏΠΎΡΠΊΠΎΠ»ΡŒΠΊΡƒ Сдиная ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊΠ° ΠΈ Π½ΠΎΡ€ΠΌΡ‹ Π½Π΅ всСгда ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡŽΡ‚ ΠΊΠΎΡ€Ρ€Π΅ΠΊΡ‚Π½ΠΎ ΠΎΡ†Π΅Π½ΠΈΠ²Π°Ρ‚ΡŒ ΠΏΡ€ΠΎΡ„ΠΈΠ»ΡŒ примСсСй Π² субстанциях, ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Ρ… Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹ΠΌ способом. ЀармакопСя БША Π² настоящСС врСмя ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΡƒΠ΅Ρ‚ Π²ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅ Π² ΠΌΠΎΠ½ΠΎΠ³Ρ€Π°Ρ„ΠΈΠΈ Π½Π° лСкарствСнныС срСдства Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΈΠΊ для контроля примСсСй, ΠΏΡ€ΠΈ этом ΠΌΠΎΠ³ΡƒΡ‚ Ρ€Π°Π·Π»ΠΈΡ‡Π°Ρ‚ΡŒΡΡ Ρ‚Π°ΠΊΠΆΠ΅ ΠΈ Π½ΠΎΡ€ΠΌΡ‹. Π’Π°ΠΊΠΎΠΉ ΠΏΠΎΠ΄Ρ…ΠΎΠ΄ ΠΌΠΎΠΆΠ΅Ρ‚ Π±Ρ‹Ρ‚ΡŒ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ ΠΈ Π² Π“Π€ Π Π€

    Risk factors for development of lung fat embolism in casualties with severe mechanical trauma

    Get PDF
    One of the common and difficult to predict complications of injuries is fat embolism. Lethality rate is up to 67% even with intensive modern therapy. The variety of manifestations of fat embolism, the lack of a unified theory of its occurrence and development, the multiplicity and ambiguity of risk factors for fat embolism make it necessary to study in detail the risk factors for the development of fat embolism for its effective prevention and timely therapy. The results of forensic studies of corpses have been studied. The risk of fat embolism is correlated with the functional state of the organism at the time of injury, the peculiarities of injury, the presence and duration of medical care. Statistical processing of the obtained data using the program MedCalc Statistical for biomedical research, software manual (2014) has been performed. Direct negative regression of the ratio of soft tissue and internal organ damage to the degree of fat embolism has been reliably revealed. A slight direct positive regression between the extent of skeletal bone damage and the degree of fat embolism has been found. The development of fat embolism is associated with the presence of infectious and inflammatory processes in the lungs in 30-40% of cases. The fact of polytrauma does not significantly affect the degree of fat embolism. It was reliably determined that a high degree of fat embolism in a smaller part of cases was diagnosed with a combination of soft tissue damage and internal organs. Currently, the existing schemes of medical care for victims do not have a significant impact on the development of fat embolism. A detailed analysis of the provisions of biochemical and colloidal-chemical theories of fat embolism development is necessary for the development and implementation of recommendations for the prevention of embolism in certain categories of traumatological patients.Одним ΠΈΠ· часто Π²ΡΡ‚Ρ€Π΅Ρ‡Π°ΡŽΡ‰ΠΈΡ…ΡΡ ΠΈ слоТно прСдсказуСмых ослоТнСний Ρ‚Ρ€Π°Π²ΠΌ являСтся Тировая эмболия. Π›Π΅Ρ‚Π°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ, нСсмотря Π½Π° ΠΈΠ½Ρ‚Π΅Π½ΡΠΈΠ²Π½ΡƒΡŽ ΡΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΡƒΡŽ Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ, составляСт Π΄ΠΎ 67%. Π’ настоящСС врСмя ΠΌΠ½ΠΎΠ³ΠΎΠΎΠ±Ρ€Π°Π·ΠΈΠ΅ проявлСний ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии, отсутствиС Π΅Π΄ΠΈΠ½ΠΎΠΉ Ρ‚Π΅ΠΎΡ€ΠΈΠΈ Π΅Π΅ возникновСния ΠΈ развития, Π° Ρ‚Π°ΠΊΠΆΠ΅ ΠΌΠ½ΠΎΠΆΠ΅ΡΡ‚Π²Π΅Π½Π½ΠΎΡΡ‚ΡŒ ΠΈ Π½Π΅ΠΎΠ΄Π½ΠΎΠ·Π½Π°Ρ‡Π½ΠΎΡΡ‚ΡŒ Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² риска развития ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии ΠΎΠΏΡ€Π΅Π΄Π΅Π»ΡΡŽΡ‚ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌΠΎΡΡ‚ΡŒ Π³Π»ΡƒΠ±ΠΎΠΊΠΎΠ³ΠΎ изучСния Ρ„Π°ΠΊΡ‚ΠΎΡ€ΠΎΠ² риска ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии для Π΅Π΅ эффСктивной ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠΈ ΠΈ своСврСмСнной Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. Π‘Ρ‹Π»ΠΈ ΠΈΠ·ΡƒΡ‡Π΅Π½Ρ‹ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ судСбно-мСдицинских исслСдований Ρ‚Ρ€ΡƒΠΏΠΎΠ². Для опрСдСлСния риска ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии ΡƒΡ‡ΠΈΡ‚Ρ‹Π²Π°Π»ΠΈΡΡŒ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ΅ состояниС ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌΠ° Π½Π° ΠΌΠΎΠΌΠ΅Π½Ρ‚ Ρ‚Ρ€Π°Π²ΠΌΡ‹, особСнности поврСТдСния Ρ‚ΠΊΠ°Π½Π΅ΠΉ ΠΈ ΠΎΡ€Π³Π°Π½ΠΎΠ², Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ ΠΈ Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ оказания мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ. БтатистичСская ΠΎΠ±Ρ€Π°Π±ΠΎΡ‚ΠΊΠ° ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Ρ… Π΄Π°Π½Π½Ρ‹Ρ… Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½Π° с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ MedCalc Statistic for biomedical research, software manual 2014. достовСрно выявлСна прямая ΠΎΡ‚Ρ€ΠΈΡ†Π°Ρ‚Π΅Π»ΡŒΠ½Π°Ρ рСгрСссия ΡΠΎΠΎΡ‚Π½ΠΎΡˆΠ΅Π½ΠΈΡ объСма ΠΏΠΎΠ²Ρ€Π΅ΠΆΠ΄Π΅Π½ΠΈΠΉ мягких Ρ‚ΠΊΠ°Π½Π΅ΠΉ ΠΈ Π²Π½ΡƒΡ‚Ρ€Π΅Π½Π½ΠΈΡ… ΠΎΡ€Π³Π°Π½ΠΎΠ² со ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒΡŽ ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии; ΠΌΠ΅ΠΆΠ΄Ρƒ объСмом поврСТдСния костСй скСлСта ΠΈ ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒΡŽ ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии выявлСна Π½Π΅Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ прямая ΠΏΠΎΠ»ΠΎΠΆΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ рСгрСссия. Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии сопряТСно с Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ΠΌ ΠΈΠ½Ρ„Π΅ΠΊΡ†ΠΈΠΎΠ½Π½ΠΎ-Π²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… процСссов Π² Π»Π΅Π³ΠΊΠΈΡ… Π² 30-40% случаСв. Π‘Π΄Π΅Π»Π°Π½Ρ‹ Π²Ρ‹Π²ΠΎΠ΄Ρ‹ ΠΎ Ρ‚ΠΎΠΌ, Ρ‡Ρ‚ΠΎ Ρ„Π°ΠΊΡ‚ ΠΏΠΎΠ»ΠΈΡ‚Ρ€Π°Π²ΠΌΡ‹ достовСрно практичСски Π½Π΅ влияСт Π½Π° ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒ ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии, Π½ΠΎ достовСрно выявлСно, Ρ‡Ρ‚ΠΎ высокая ΡΡ‚Π΅ΠΏΠ΅Π½ΡŒ ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии Π² мСньшСй части случаСв диагностирована ΠΏΡ€ΠΈ сочСтании поврСТдСния мягких Ρ‚ΠΊΠ°Π½Π΅ΠΉ ΠΈ Π²Π½ΡƒΡ‚Ρ€Π΅Π½Π½ΠΈΡ… ΠΎΡ€Π³Π°Π½ΠΎΠ². Π’ настоящСС врСмя ΡΡƒΡ‰Π΅ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΠ΅ схСмы оказания мСдицинской ΠΏΠΎΠΌΠΎΡ‰ΠΈ ΠΏΠΎΡΡ‚Ρ€Π°Π΄Π°Π²ΡˆΠΈΠΌ Π½Π΅ ΠΎΠΊΠ°Π·Ρ‹Π²Π°ΡŽΡ‚ сущСствСнного влияния Π½Π° Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии. Π’ связи с Π²Ρ‹ΡˆΠ΅ΡΠΊΠ°Π·Π°Π½Π½Ρ‹ΠΌ Π½Π΅ΠΎΠ±Ρ…ΠΎΠ΄ΠΈΠΌ Π΄Π΅Ρ‚Π°Π»ΡŒΠ½Ρ‹ΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΠΉ биохимичСской ΠΈ ΠΊΠΎΠ»Π»ΠΎΠΈΠ΄Π½ΠΎ-химичСской Ρ‚Π΅ΠΎΡ€ΠΈΠΉ развития ΠΆΠΈΡ€ΠΎΠ²ΠΎΠΉ эмболии для Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ ΠΈ внСдрСния Ρ€Π΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°Ρ†ΠΈΠΉ ΠΏΠΎ ΠΏΡ€ΠΎΡ„ΠΈΠ»Π°ΠΊΡ‚ΠΈΠΊΠ΅ эмболии Ρƒ ΠΎΠΏΡ€Π΅Π΄Π΅Π»Π΅Π½Π½Ρ‹Ρ… ΠΊΠ°Ρ‚Π΅Π³ΠΎΡ€ΠΈΠΉ травматологичСских Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…
    corecore